Literature DB >> 31369044

Circulating Tumor DNA as a Marker for Disease Relapse in Early-Stage Breast Cancer-Bad Blood.

Swathi Karthikeyan1, Ben Ho Park1,2.   

Abstract

Year:  2019        PMID： 31369044     DOI： 10.1001/jamaoncol.2019.2047

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  3 in total

1.  ctDNA as promising tool for the assessment of minimal residual disease (MRD) and the need of an adjuvant treatment in gastroesophageal adenocarcinoma.

Authors:  Vittoria Matilde Piva; Maria Caterina De Grandis; Michele Valmasoni; Sara Lonardi; Irene Sole Zuin; Valentina Angerilli; Floriana Nappo; Rita Alfieri; Selma Ahcene Djaballah; Sabina Murgioni; Francesca Bergamo; Matteo Fassan
Journal:  Updates Surg       Date:  2022-10-22

Review 2.  The History and Future of Basic and Translational Cell-Free DNA Research at a Glance.

Authors:  Peter B Gahan; Heidi Schwarzenbach; Philippe Anker
Journal:  Diagnostics (Basel)       Date:  2022-05-10

Review 3.  Ibrutinib in Refractory or Relapsing Primary Central Nervous System Lymphoma: A Systematic Review.

Authors:  Gaurav Nepal; Mahika Khurana; Domenica Herrera Bucheli; Siddhartha Bhandari; Utsav Joshi; Riwaj Bhagat; Jessica Holly Rehrig; Prasun Pudasainee; Yow Ka Shing; Juan Fernando Ortiz; Rajeev Ojha; Bikram Prasad Gajurel; Jonathan Quinonez; Samir Ruxmohan; Trevine Albert; Steven Licata; Joel Stien
Journal:  Neurol Int       Date:  2022-01-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.